FR08C0024I2 - - Google Patents

Info

Publication number
FR08C0024I2
FR08C0024I2 FR08C0024C FR08C0024C FR08C0024I2 FR 08C0024 I2 FR08C0024 I2 FR 08C0024I2 FR 08C0024 C FR08C0024 C FR 08C0024C FR 08C0024 C FR08C0024 C FR 08C0024C FR 08C0024 I2 FR08C0024 I2 FR 08C0024I2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR08C0024C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8870899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR08C0024(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of FR08C0024I1 publication Critical patent/FR08C0024I1/fr
Application granted granted Critical
Publication of FR08C0024I2 publication Critical patent/FR08C0024I2/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR08C0024C 2001-12-21 2008-06-05 Active FR08C0024I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116747A FR2833841B1 (fr) 2001-12-21 2001-12-21 Gel comprenant au moins un retinoide et du peroxyde de benzoyle
PCT/FR2002/004233 WO2003055472A1 (fr) 2001-12-21 2002-12-09 Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Publications (2)

Publication Number Publication Date
FR08C0024I1 FR08C0024I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2008-07-18
FR08C0024I2 true FR08C0024I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2009-11-20

Family

ID=8870899

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0116747A Expired - Fee Related FR2833841B1 (fr) 2001-12-21 2001-12-21 Gel comprenant au moins un retinoide et du peroxyde de benzoyle
FR08C0024C Active FR08C0024I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2001-12-21 2008-06-05

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR0116747A Expired - Fee Related FR2833841B1 (fr) 2001-12-21 2001-12-21 Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Country Status (22)

Country Link
EP (1) EP1458369B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JP4889922B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR101014586B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1329025C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR038026A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE347354T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU2002364437B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BRPI0214264B8 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2466321C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1107583T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE60216634T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK1458369T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2275948T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR2833841B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU230439B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA04005918A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL220838B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT1458369E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2320327C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (1) SI1458369T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2003055472A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200403759B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
EP1813312A3 (en) * 2002-09-05 2010-03-24 Galderma Research & Development Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
ATE467411T1 (de) * 2004-11-09 2010-05-15 Imaginative Res Associates Inc Retinoidlösungen und formulierungen daraus
EP1919606A2 (en) 2005-08-02 2008-05-14 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
FR2889662B1 (fr) * 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
FR2890314B1 (fr) * 2005-09-02 2009-03-20 Galderma Res & Dev Compositiondepigmentante de la peau comprenant de l'adapalene au moins un agent depigmentant et au moins un agent anti-inflammatoire
CA2616915A1 (en) * 2005-09-02 2007-05-10 Isabelle Pelisson Depigmenting composition for the skin, comprising adapalene, at least one depigmenting agent and at least one anti-inflammatory agent
ES2582654T3 (es) 2006-03-31 2016-09-14 Stiefel Research Australia Pty Ltd Gel en suspensión espumable
FR2901139B1 (fr) * 2006-05-17 2009-03-20 Galderma Res & Dev S N C Snc Compositions comprenant au moins un derive de l'acide naphtoique et du peroxyde de benzoyle, leurs procedes de preparation, et leurs utilisations
FR2903603B1 (fr) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
US8080537B2 (en) 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
FR2903604B1 (fr) * 2006-07-13 2008-09-05 Galderma Res & Dev S N C Snc Composition comprenant un retinoide et du peroxyde de benzoyle
JP5317968B2 (ja) * 2006-07-13 2013-10-16 ガルデルマ・リサーチ・アンド・デヴェロップメント レチノイドと過酸化ベンゾイルとを含む組成物
FR2909000B1 (fr) * 2006-11-28 2009-02-06 Galderma Res & Dev S N C Snc Compositions comprenant du peroxyde de benzoyle, au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethane ou des derives de celui-ci, et leurs utilisations.
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
EP2114392B1 (en) 2007-01-30 2015-06-10 Galderma Research & Development Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris
US20100047357A1 (en) * 2007-02-01 2010-02-25 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
EA018275B1 (ru) 2007-02-01 2013-06-28 Сол-Джел Текнолоджиз Лтд. Способ получения частиц, содержащих покрытие из оксида металла, и частицы с покрытием из оксида металла
EP1967180A1 (de) * 2007-03-06 2008-09-10 Almirall Hermal GmbH Topische Zusammensetzung enthaltend einen Retinoid-Rezeptor-Agonist
FR2916975B1 (fr) * 2007-06-11 2009-09-04 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
EP2065032A1 (en) * 2007-11-27 2009-06-03 Galderma Research & Development A method for producing adapalene gels
EP2224908B1 (fr) * 2007-11-30 2017-11-01 Galderma Research & Development Compositions comprenant au moins un derive de l'acide naphtoïque, du peroxyde de benzoyle et au moins un agent filmogene.
MX2010013152A (es) 2008-06-05 2011-05-02 Dow Pharmaceutical Sciences Formulaciones farmaceuticas topicas que contienen una baja concentracion de peroxido de benzoilo en suspension en agua y un solvente organico miscibe en agua.
DK2365829T3 (en) 2008-11-07 2017-07-31 Klox Tech Inc COMBINATION OF AN OXIDANT AND PHOTO ACTIVATOR FOR HEALING OF WOES
CN102686208A (zh) 2009-10-07 2012-09-19 塔格拉生物科技有限公司 包含过氧化苯甲酰的微胶囊和包含所述微胶囊的局部用组合物
BR112012009644A2 (pt) * 2009-10-21 2015-09-29 Dow Pharmaceutical Sciences método para umedecer um pó contendo o peróxido de benzoíla
EP2533776A1 (en) 2010-02-09 2012-12-19 Galderma Research & Development A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation
FR2969491B1 (fr) * 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
FR2969492B1 (fr) * 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
US8563535B2 (en) 2011-03-29 2013-10-22 Kamal Mehta Combination composition comprising benzoyl peroxide and adapalene
JP2015517559A (ja) 2012-05-25 2015-06-22 ガルデルマ・リサーチ・アンド・デヴェロップメント 思春期前中程度の尋常性ざ瘡の治療
LT2919747T (lt) * 2012-11-13 2018-12-27 Galderma S.A. Bpo (benzoilperoksido) prausiklio gelio kompozicija
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
JP2017500328A (ja) 2013-12-19 2017-01-05 ガルデルマ・リサーチ・アンド・デヴェロップメント 重度のざ瘡に関連した疾患を処置する治療レジメン
RU2016142678A (ru) 2014-04-01 2018-05-07 Галдерма Ресерч Энд Девелопмент Способ лечения и/или предотвращения постугревых рубцов с помощью фиксированной комбинации адапалена или его солей и пероксида бензоила
CN107072939A (zh) 2014-07-25 2017-08-18 盖尔德马研究及发展公司 用于治疗严重痤疮的阿达帕林和过氧化苯甲酰的组合
MX378402B (es) * 2015-08-20 2025-03-10 Sol Gel Tech Ltd Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.
WO2018080284A1 (ko) * 2016-10-31 2018-05-03 (주)동구바이오제약 여드름 치료용 약물의 생체이용률을 증진시키는 약학적 조성물
CN106729722B (zh) * 2016-11-21 2020-05-12 成都山信药业有限公司 一种制备稳定复方制剂的方法及复方制剂
EP3651756B1 (en) 2017-07-12 2025-09-03 Sol-Gel Technologies Ltd. Compositions comprising encapsulated tretinoin
SG11202111028YA (en) * 2019-04-04 2021-11-29 Galderma Hoding Sa Isopropylcarbonate benzoyl peroxide compositions and methods of use
JPWO2023112664A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 2021-12-14 2023-06-22
EP4493179A1 (en) * 2022-03-14 2025-01-22 Blue Hill Technologies LLC Shelf-stable formulations of benzoyl peroxide and methods of producing same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne
US4189501A (en) * 1977-10-07 1980-02-19 A. H. C. Pharmacal, Inc. Composition and method for the treatment of acne
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
FR2628319B1 (fr) * 1988-03-09 1990-12-07 Oreal Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de sels d'ammonium quaternaires
ATE133560T1 (de) * 1991-10-16 1996-02-15 Richardson Vicks Inc Wässeriges,kosmetisches gel,mit niedrigem ph,das nichtionogene polyacrylamidderivate enthält
US5470884A (en) * 1994-05-19 1995-11-28 Procter & Gamble Anti-acne compositions
FR2785284B1 (fr) * 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
WO2001045647A2 (de) * 1999-12-20 2001-06-28 Henkel Kommanditgesellschaft Auf Aktien Tablettierung verdickender systeme
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Also Published As

Publication number Publication date
CN1607946A (zh) 2005-04-20
RU2004122429A (ru) 2005-03-20
PL372270A1 (en) 2005-07-11
ATE347354T1 (de) 2006-12-15
HUP0500006A2 (en) 2006-08-28
CA2466321C (fr) 2011-11-08
RU2320327C2 (ru) 2008-03-27
BRPI0214264B8 (pt) 2021-05-25
DE60216634D1 (de) 2007-01-18
KR101014586B1 (ko) 2011-02-16
FR2833841A1 (fr) 2003-06-27
DK1458369T3 (da) 2007-04-10
FR2833841B1 (fr) 2005-07-22
BRPI0214264B1 (pt) 2017-04-18
DE60216634T2 (de) 2007-09-27
JP5478468B2 (ja) 2014-04-23
BR0214264A (pt) 2004-09-21
WO2003055472A1 (fr) 2003-07-10
DE122008000041I1 (de) 2008-11-20
AU2002364437B2 (en) 2008-08-21
CA2466321A1 (fr) 2003-07-10
KR20050016290A (ko) 2005-02-21
HU230439B1 (hu) 2016-06-28
ES2275948T3 (es) 2007-06-16
AR038026A1 (es) 2004-12-22
JP4889922B2 (ja) 2012-03-07
AU2008246274A1 (en) 2008-12-11
FR08C0024I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2008-07-18
EP1458369B1 (fr) 2006-12-06
ZA200403759B (en) 2005-11-30
CY1107583T1 (el) 2013-03-13
EP1458369A1 (fr) 2004-09-22
MXPA04005918A (es) 2004-11-01
AU2008246274B2 (en) 2011-05-19
HUP0500006A3 (en) 2009-09-28
SI1458369T1 (sl) 2007-04-30
AU2002364437A1 (en) 2003-07-15
JP2011037904A (ja) 2011-02-24
PL220838B1 (pl) 2016-01-29
JP2005513146A (ja) 2005-05-12
CN1329025C (zh) 2007-08-01
PT1458369E (pt) 2007-03-30

Similar Documents

Publication Publication Date Title
BE2022C531I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2022C502I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2017C059I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2017C056I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2017C051I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2017C032I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2016C051I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2015C046I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR08C0024I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2017C050I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2014C052I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2014C036I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2014C026I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2002080162A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2014C006I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2002200039A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH1379220H1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2014C008I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2016C021I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2002048342A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2002210742A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BRPI0101486B8 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2002032035A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2012C051I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2001243063A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)